miRNA therapeutics

At the Rodman & Renshaw Healthcare Conference in New York this Week, a company official noted that in work conducted with Mirna Therapeutics, Marina found a 100-fold increase in microRNA in three different tissues, along with downregulation of the intended gene targets.

The company has exclusively licensed inventions related to the modulation of miR-146 and miR-155, key mediators of the inflammatory response.

People in the News

Premium

Chris Earl, Corey Goodman, Evan Melrose

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.